Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Supplements vs Yasmin for PMS
NCT02089620Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of drospirenone in premenstrual syndrome (PMS) (3 arms), sponsored by Beni Suef University. Primary endpoint: Improvement of premenstrual symptoms at 3 months. Started May 2014; status: completed.
02
Drugs
drospirenone
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT02089620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089620.